Silence Therapeutics Competes with Takeda in Rare Blood Cancer Treatment

A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine. The company aims to silence the competition by presenting new data.